These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35565391)

  • 1. Space- and Time-Resolved Metabolomics of a High-Grade Serous Ovarian Cancer Mouse Model.
    Sah S; Ma X; Botros A; Gaul DA; Yun SR; Park EY; Kim O; Moore SG; Kim J; Fernández FM
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model.
    Huang D; Gaul DA; Nan H; Kim J; Fernández FM
    J Proteome Res; 2019 Aug; 18(8):3184-3194. PubMed ID: 31290664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Microchip Capillary Electrophoresis-Orbitrap Mass Spectrometry Metabolomics to Monitor Ovarian Cancer Progression.
    Sah S; Yun SR; Gaul DA; Botros A; Park EY; Kim O; Kim J; Fernández FM
    Metabolites; 2022 Jun; 12(6):. PubMed ID: 35736465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrahigh Resolution Lipid Mass Spectrometry Imaging of High-Grade Serous Ovarian Cancer Mouse Models.
    Ma X; Botros A; Yun SR; Park EY; Kim O; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models.
    Ma X; Botros A; Yun SR; Park EY; Kim O; Park S; Pham TH; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
    Front Chem; 2023; 11():1332816. PubMed ID: 38260043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model.
    Jones CM; Monge ME; Kim J; Matzuk MM; Fernández FM
    J Proteome Res; 2015 Feb; 14(2):917-27. PubMed ID: 25567202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.
    Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM
    J Proteome Res; 2023 Jun; 22(6):2092-2108. PubMed ID: 37220064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.
    Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.
    Sans M; Gharpure K; Tibshirani R; Zhang J; Liang L; Liu J; Young JH; Dood RL; Sood AK; Eberlin LS
    Cancer Res; 2017 Jun; 77(11):2903-2913. PubMed ID: 28416487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging.
    Wang Z; Fu W; Huo M; He B; Liu Y; Tian L; Li W; Zhou Z; Wang B; Xia J; Chen Y; Wei J; Abliz Z
    Acta Pharm Sin B; 2021 Nov; 11(11):3665-3677. PubMed ID: 34900545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Origins of High-Grade Serous Ovarian Cancer.
    Kim J; Park EY; Kim O; Schilder JM; Coffey DM; Cho CH; Bast RC
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary.
    Gutkin DW; Shurin MR; El Azher MA; Shurin GV; Velikokhatnaya L; Prosser D; Shin N; Modugno F; Stemmer P; Elishaev E; Lokshin A
    Cancer Biomark; 2019; 26(4):471-479. PubMed ID: 31658047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.
    Dahl ES; Buj R; Leon KE; Newell JM; Imamura Y; Bitler BG; Snyder NW; Aird KM
    Mol Cancer Res; 2019 Aug; 17(8):1710-1720. PubMed ID: 31110157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse Model.
    Paine MR; Kim J; Bennett RV; Parry RM; Gaul DA; Wang MD; Matzuk MM; Fernández FM
    PLoS One; 2016; 11(5):e0154837. PubMed ID: 27159635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
    Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
    Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive high-resolution mass spectrometry approach for characterization of metabolites by combination of ambient ionization, chromatography and imaging methods.
    Berisha A; Dold S; Guenther S; Desbenoit N; Takats Z; Spengler B; Römpp A
    Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1779-91. PubMed ID: 25559448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of serum human epididymal secretory protein E4 at low grade and high grade serous carcinomas.
    Zhu YF; He LS; Zhang ZD; Huang QS
    Asian Pac J Trop Med; 2012 Dec; 5(12):925-30. PubMed ID: 23199707
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.